1. Home
  2. STRA vs TNGX Comparison

STRA vs TNGX Comparison

Compare STRA & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$80.63

Market Cap

1.8B

Sector

Real Estate

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$19.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
TNGX
Founded
2017
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
STRA
TNGX
Price
$80.63
$19.29
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$96.50
$18.75
AVG Volume (30 Days)
318.0K
3.5M
Earning Date
04-23-2026
03-05-2026
Dividend Yield
2.96%
N/A
EPS Growth
15.85
26.89
EPS
5.41
N/A
Revenue
$997,137,000.00
$62,384,000.00
Revenue This Year
$3.93
N/A
Revenue Next Year
$4.93
N/A
P/E Ratio
$14.95
N/A
Revenue Growth
57.23
48.29
52 Week Low
$72.17
$1.04
52 Week High
$92.98
$19.55

Technical Indicators

Market Signals
Indicator
STRA
TNGX
Relative Strength Index (RSI) 49.83 75.56
Support Level $78.87 $5.98
Resistance Level $82.77 N/A
Average True Range (ATR) 2.69 1.26
MACD 0.01 0.34
Stochastic Oscillator 34.92 91.12

Price Performance

Historical Comparison
STRA
TNGX

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: